Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Linking artificial intelligence to neurostimulation opens up a world of new possibilities for treating pain and other conditions

By Mindo - 22nd Oct 2019 | 32 views

Linking brain stimulation to artificial intelligence (AI) could open up a world of new possibilities in the treatment of pain and many other conditions, delegates at the European Pain Federation’s biennial Congress in Valencia, Spain, in September were told.

Neurosurgeon Prof Dirk De Ridder told the 3,500 delegates in a keynote address that AI could act as ‘software’ that could tailor treatment to individual patients suffering from a great variety of different medical and psychological conditions.

“Neurostimulation started off by just sending single pulses to the brain. I have developed a new device that now sends bursts of pulses, which tells the brain ‘this is really important — you have to respond to it’. It can be used to target specific circuits in the brain, which are often linked to a number of different conditions, and so treat conditions such as phantom sounds (tinnitus) or phantom pains, depression, OCD, Parkinson’s disease, and even addictions.”

He continued: “But even this is still quite primitive. The aim now is to mimic the way a human brain communicates with itself. For example, different brain circuits use different frequencies, just like a radio. We have already managed to recreate this, using non-invasive techniques. Looking further ahead, though, we need to integrate AI, which is already being used constantly on our smartphones, into those neurostimulators. Effectively, what we have now is the hardware for neurostimulation, but not the software. AI has the potential to become that software.”

He said that in the future, 10-to-20 years ahead, the AI software will act as a ‘small brain’ in itself, so it can first recognise abnormal patterns in the brain (ie, identifying that a person is feeling a certain level of pain, or stress — or perhaps is suffering alcohol cravings because they are passing a bar — then the AI will automatically adjust the stimulation design at precisely the right time and in the right circumstances to modulate the brain signals, alleviate the discomforts and also create deep learning in the brain.”

Prof De Ridder noted that there were already a number of organisations investing enormous sums of money researching the potential of neurostimulation so that, even further into the future, he could envisage there being electronic interfaces between human brains and the Internet.

“We can already read memories in animals and then transfer these memories into other animals… The next big thing may be to connect brains via the Internet, so that, for example, a husband or wife travelling can kiss their partner goodnight from thousands of miles away and their partner will be able to feel it. It’s not so very far off.”

Other highlights at the EFIC Congress included presentations on the relationship between gender and migraines; how pain is experienced differently between different age-groups; how the evolution of digital healthcare will impact pain treatment; and whether there is ‘an opioid crisis’ in Europe.

The Congress, which took place between 4-7 September, was the largest scientific congress on pain in 2019, bringing together the most recognised experts in the field of pain medicine to exchange knowledge, ideas and the latest advances in the field.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read